Metastatic clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer
open to eligible people ages 18 years and up
A phase IIb, open-label, randomized study of Nab-Paclitaxel and Gemcitabine and plus/minus VCN-01 in Patients with Metastatic Pancreatic Cancer
at UC Davis
Our lead scientists for Metastatic research studies include Edward Kim, MD, PhD.
Last updated: